Medical Product Sales and Marketing Veteran Patrick Moan, MBA,
to Build Company's Hybrid Sales Force
NORTHBROOK, Ill., Aug. 5, 2024
/PRNewswire-PRWeb/ -- ASP Health Inc., a private medical device
company focused on developing and commercializing innovative sample
preparation technology to enhance and expand cancer diagnosis,
today announced that Patrick Moan,
MBA, has joined the company as its first National Sales Director.
Mr. Moan will create a hybrid sales force to commercialize the
company's ROSE PrepTM system in the U.S., and create mutually
beneficial regional relationships with external stakeholders.
Patrick will build a sales team composed of
direct representatives and channel partners, enabling our system to
provide enhanced patient care in the field of oncology. -- ASP
Health EVP and CCO Hari Subramanian, PhD, MBA
Mr. Moan brings to ASP Health more than 15 years of sales and
marketing experience with a focus on medical diagnostics offering
disruptive technologies. Before joining ASP Health, Mr. Moan served
as Regional Sales Director - US at Somatex Medical Technologies, a
Hologic company, where he was accountable for the commercialization
of breast biopsy implantable devices, and other technologies
through a hybrid sales force of direct representatives and
distribution partners. Previously, Mr. Moan held sales management
and individual contributor positions at Draeger North America,
Mindray North America/Datascope, BD Diagnostics, Nova Biomedical,
and Moog Medical. Mr. Moan earned his MBA from Aurora University in Aurora, IL.
"Patrick's proven track record of working with early-stage
companies to launch new products through a hybrid sales force, his
experience working with pathology and pulmonology customers, and
his deep understanding of the cancer diagnostic marketplace, make
him perfectly suited to direct the launch of our ROSE PrepTM
system," said ASP Health Executive Vice President and Chief
Commercial Officer Hari Subramanian,
PhD, MBA. "Patrick will build a sales team composed of direct
representatives and channel partners, enabling our system to
provide enhanced patient care in the field of oncology."
"I know this market indication very well and believe there is a
significant unmet need that the ROSE Prep™ system will be able to
address immediately in the diagnostic space. The scalability of our
platform will allow us to meet future market needs, including
utilizing machine learning to streamline diagnosis. I am thrilled
to have the opportunity to apply my nearly 20 years of experience
in medical devices, capital equipment, and diagnostics to lead the
US market with our commercialization strategy."
About ASP Health
ASP Health is a private medical device company focused on
developing and commercializing innovative sample preparation
technology to enhance and expand cancer diagnosis. ASP Health
partners with Planet Innovation, a world-class company known for
creating breakthrough products and commercially successful
businesses. Its expertise in the research, design, engineering,
manufacture, and marketing of new products is accelerating our
product development and commercialization efforts. For more
information, please visit asp-health.com.
ROSE is a laboratory test that must be performed in accordance
with the mandates of CLIA. The scope of practice for a ROSE service
is dependent on the needs of the individual health care environment
and best determined by the physicians and health care providers in
each unique practice setting. The ASP Device may only be used with
the General-Purpose Reagents that are recommended for use with the
device. Other reagents can be used after they are independently
validated by the users of the ASP Device. Sites are responsible to
follow the most current version of the CLIA regulations Part
493.
Media Contact
Hari Subramanian, ASP Health
Inc., 1 (425) 241-7385, hariharan@asp-health.com,
asp-health.com
View original content to download
multimedia:https://www.prweb.com/releases/asp-health-inc-expands-executive-team-with-its-first-national-sales-director-302213980.html
SOURCE ASP Health Inc.